[MAYBANK] QoQ Cumulative Quarter Result on 31-Mar-2007 [#3]

Announcement Date
11-May-2007
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2007
Quarter
31-Mar-2007 [#3]
Profit Trend
QoQ- 56.18%
YoY- 9.21%
View:
Show?
Cumulative Result
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
Revenue 7,923,875 3,922,105 15,179,312 10,966,214 7,000,075 3,540,112 12,754,491 -27.12%
PBT 2,047,331 1,014,102 4,363,698 3,032,399 2,004,247 870,833 3,988,065 -35.80%
Tax -569,189 -262,141 -1,110,827 -847,522 -589,829 -284,910 -1,153,481 -37.47%
NP 1,478,142 751,961 3,252,871 2,184,877 1,414,418 585,923 2,834,584 -35.13%
-
NP to SH 1,466,383 735,429 3,178,372 2,125,566 1,360,955 568,681 2,772,418 -34.52%
-
Tax Rate 27.80% 25.85% 25.46% 27.95% 29.43% 32.72% 28.92% -
Total Cost 6,445,733 3,170,144 11,926,441 8,781,337 5,585,657 2,954,189 9,919,907 -24.92%
-
Net Worth 19,418,866 19,903,276 15,198,683 15,343,511 17,796,929 17,738,551 16,741,323 10.36%
Dividend
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
Div 1,265,465 680,952 3,079,071 1,534,351 1,527,371 - 3,203,035 -46.06%
Div Payout % 86.30% 92.59% 96.88% 72.19% 112.23% - 115.53% -
Equity
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
Net Worth 19,418,866 19,903,276 15,198,683 15,343,511 17,796,929 17,738,551 16,741,323 10.36%
NOSH 3,893,741 3,891,158 3,848,839 3,835,877 3,818,427 3,801,742 3,768,276 2.20%
Ratio Analysis
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
NP Margin 18.65% 19.17% 21.43% 19.92% 20.21% 16.55% 22.22% -
ROE 7.55% 3.70% 20.91% 13.85% 7.65% 3.21% 16.56% -
Per Share
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
RPS 203.50 100.80 394.39 285.89 183.32 93.12 338.47 -28.69%
EPS 37.66 18.90 66.07 44.33 35.64 14.96 73.57 -35.93%
DPS 32.50 17.50 80.00 40.00 40.00 0.00 85.00 -47.22%
NAPS 4.9872 5.115 3.9489 4.00 4.6608 4.6659 4.4427 7.98%
Adjusted Per Share Value based on latest NOSH - 3,869,835
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
RPS 65.68 32.51 125.82 90.90 58.02 29.34 105.72 -27.12%
EPS 12.15 6.10 26.35 17.62 11.28 4.71 22.98 -34.53%
DPS 10.49 5.64 25.52 12.72 12.66 0.00 26.55 -46.06%
NAPS 1.6096 1.6498 1.2598 1.2718 1.4752 1.4703 1.3877 10.36%
Price Multiplier on Financial Quarter End Date
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
Date 31/12/07 28/09/07 29/06/07 30/03/07 29/12/06 29/09/06 30/06/06 -
Price 11.50 11.00 12.00 12.80 11.80 11.20 10.70 -
P/RPS 5.65 10.91 3.04 4.48 6.44 12.03 3.16 47.15%
P/EPS 30.54 58.20 14.53 23.10 33.11 74.87 14.54 63.78%
EY 3.27 1.72 6.88 4.33 3.02 1.34 6.88 -39.01%
DY 2.83 1.59 6.67 3.13 3.39 0.00 7.94 -49.63%
P/NAPS 2.31 2.15 3.04 3.20 2.53 2.40 2.41 -2.77%
Price Multiplier on Announcement Date
31/12/07 30/09/07 30/06/07 31/03/07 31/12/06 30/09/06 30/06/06 CAGR
Date 20/02/08 15/11/07 29/08/07 11/05/07 21/02/07 14/11/06 24/08/06 -
Price 9.80 11.40 11.60 12.40 13.20 11.50 10.80 -
P/RPS 4.82 11.31 2.94 4.34 7.20 12.35 3.19 31.57%
P/EPS 26.02 60.32 14.05 22.38 37.04 76.88 14.68 46.30%
EY 3.84 1.66 7.12 4.47 2.70 1.30 6.81 -31.67%
DY 3.32 1.54 6.90 3.23 3.03 0.00 7.87 -43.66%
P/NAPS 1.97 2.23 2.94 3.10 2.83 2.46 2.43 -13.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment